Biosimilars

3 results found for: biosimilars

Most expensive NHS drug comes off patent

Adalimumab (Humira; AbbVie) is a biological medicine used to treat conditions including rheumatoid arthritis and Crohn’s disease

Biosimilars & generics saved NHS £324m last year

The NHS saved £324 million by switching from using 10 medicines to “better value and equally effective alternatives” in 2017-18 – and additional savings are expected this year

Market update: generics cash flow havoc

As pharmacies in England deal with yet another substantial ‘margin recovery’ exercise, will new regulations see an end to the financial disruption?



This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.